IFNG and cytomegalovirus infection: Specifically, a lack of CMV intermediate early 1–specific CMI, defined as 40 IFN-γ spots/3 × 105 PBMCs at 2 weeks post-transplant, was correlated with CMV infection among KT recipients with basiliximab induction therapy.